Please use this identifier to cite or link to this item:
|Title:||Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care|
|Keywords:||Hypertension;Treatment guidelines;Evidence-based medicine;Jordan;NICE;LMIC|
|Publisher:||Cambridge University Press (CUP)|
|Citation:||International Journal of Technology Assessment in Health Care, 27 (02): 151 - 158, (April 2011)|
|Abstract:||The UK's National Institute for Health and Clinical Excellence (NICE) and the Jordan office of the Medicines Transparency Alliance embarked on a pilot project to design an evidence-based guideline for cost-effective pharmacological treatment of essential hypertension in Jordan. The project's objectives were to directly address a major health problem for Jordan by producing a guideline; and to delineate the strengths and weaknesses of Jordan's healthcare process to allow similar future efforts to be planned more efficiently.|
|Appears in Collections:||Health Economics Research Group (HERG)|
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.